🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Emanuel F. Petricoin

George Mason University

ORCID: 0000-0001-9146-5572
ChemistryBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
4.9Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005
Top 4%
4.9DataRank
Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Papers

Driven by 29 papers — median percentile 48. Top paper: “Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies”.

Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies

Cancer Cell(2022)10.1016/j.ccell.2022.05.005
Top 4%
4.9DataRank
Top 4%329 citations

Christina Yau, Julia Wulfkuhle, Lamorna Brown Swigart, Rosa I. Gallagher, Pei Rong Evelyn Lee +28 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z
N/A
0.900DataRank · unranked
27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0142
N/A
0.811DataRank · unranked
19 citations

Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon +10 more

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

Nature Communications(2021)10.1038/s41467-021-26019-y
N/A
0.648DataRank · unranked
74 citations

Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, L. J. van ‘t Veer, Douglas Yee +46 more

Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection

Breast Cancer Research(2020)10.1186/s13058-020-01373-9
N/A
0.546DataRank · unranked
37 citations

Khyatiben V. Pathak, Luisa Paris, Kristina Chapple, Kristine A. Tsantilas, Matthew Rosenow +14 more

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00337-2
N/A
0.510DataRank · unranked
29 citations

Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar +50 more

Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101312
N/A
0.442DataRank · unranked
18 citations

Julia Wulfkuhle, Denise M. Wolf, Lamorna Brown Swigart, Christina Yau, Nicholas O’Grady +22 more

Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101799
N/A
0.345DataRank · unranked
9 citations

Denise M. Wolf, Christina Yau, Lamorna Brown Swigart, Julie Wulfkuhle, Isela Gallagher +21 more

Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance

Cancer Biology & Therapy(2023)10.1080/15384047.2023.2269637
N/A
0.262DataRank · unranked
4 citations

Rossin Erbe, Yongwei Zhang, Theresa Guo, Zoe X. Malchiodi, Rachael Maynard +8 more

Establishment and characterization of patient-derived xenograft from leptomeningeal spread of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion

Research Square(2022)10.21203/rs.3.rs-2026518/v1
N/A
0DataRank · unranked
0 citations

Reza Saadatzadeh, Erika A. Dobrota, Josue D. Ordaz, Barbara J. Bailey, Pankita H. Pandya +17 more

Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion

Scientific Reports(2023)10.1038/s41598-023-36107-2
N/A
0DataRank · unranked
1 citations

M. Reza Saadatzadeh, Erika A. Dobrota, Josue D. Ordaz, Barbara J. Bailey, Pankita H. Pandya +17 more

Correlation of HER2 low status in I-SPY2 with molecular subtype, response, and survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.514
N/A
0DataRank · unranked
1 citations

Denise M. Wolf, Christina Yau, Emanuel F. Petricoin, Paula R. Pohlmann, Lajos Pusztai +10 more

Supplementary Table from Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1535-7163.22522299
Top 100%
0DataRank
Top 100%0 citations

Antje Schaefer, Craig M. Goodwin, Victoria V. Nguyen, Frances L. Massey, Mariaelena Pierobon +10 more

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

UNC Libraries(2024)10.17615/2caa-2659
N/A
0DataRank · unranked
24 citations

Daniel Zeitouni, Clint A. Stalnecker, Haoqiang Ying, Erik S. Knudsen, Guofang Zhang +26 more

Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers

npj Precision Oncology(2024)10.1038/s41698-024-00615-9
N/A
0DataRank · unranked
6 citations

Colin A. Martz, Andrew M. Waters, Alejandro Barrera, Annie Liu, Justine C. Rutter +15 more

Keratin 17 modulates the immune topography of pancreatic cancer

Journal of Translational Medicine(2024)10.1186/s12967-024-05252-1
N/A
0DataRank · unranked
4 citations

Michael Horowitz, Mariana Torrente-Goncalves, Lucia Roa‐Peña, Cindy V. Leiton, Mahmudul Hasan +20 more

Concurrent Inhibition of ERK and Farnesyltransferase Suppresses the Growth of HRAS Mutant Head and Neck Squamous Cell Carcinoma.

UNC Libraries(2024)10.17615/rpkf-j691
N/A
0DataRank · unranked
0 citations

Sehrish Javaid, Adrienne D. Cox, Andrew M. Waters, Antje Schaefer, Da'Jhnae Gambrell-Sanders +10 more

Proteogenomic characterization of invasive breast tumors in young women

npj Breast Cancer(2025)10.1038/s41523-025-00793-0
N/A
0DataRank · unranked
3 citations

Jianfang Liu, Anthony R. Soltis, Nicholas W. Bateman, Qingrong Chen, Lori A. Sturtz +70 more

The EGFR Pathway as a Potential Therapeutic Target for Modulation of Radiation-induced Liver Injury

Radiation Research(2025)10.1667/rade-24-00203.1
N/A
0DataRank · unranked
2 citations

Juan Dalo, Youki Ueda, Uma Shankavaram, Elisa Baldelli, Valerie Calvert +4 more

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30074-7
N/A
0DataRank · unranked
546 citations

Edik M. Blais, Jonathan R. Brody, Emily E. Lyons, Patricia DeArbeloa, Andrew Hendifar +11 more

RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling

UNC Libraries(2025)10.17615/4cr5-sf81
N/A
0DataRank · unranked
0 citations

Channing J. Der, J. Nathaniel Diehl, Huynh, Minh V, Rashid, Naim U, Adam J. Bass +15 more

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

Cancers(2020)10.3390/cancers12092392
N/A
0DataRank · unranked
342 citations

Amber L. Collier, Dasom Lee, Richard Hoefer, Vasilena Zheleva, Lauren L. Siewertsz van Reesema +11 more

Evaluation of pathogen specific urinary peptides in tick-borne illnesses

Scientific Reports(2020)10.1038/s41598-020-75051-3
N/A
0DataRank · unranked
13 citations

Raghad Almofee, Sameen Yusuf, Claudius Mueller, Ngoc Vuong, Mahmood Almosuli +21 more

The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0652
N/A
0DataRank · unranked
36 citations

Grace A. McCarthy, Teena Nerwal, Avinoam Nevler, James B. DuHadaway, Matthew McCoy +23 more

IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK

Scientific Reports(2021)10.1038/s41598-021-90289-1
N/A
0DataRank · unranked
11 citations

Adam Spencer, Sarah Hall, Jeremy J.P. Shaw, Julia Wulfkuhle, Emanuel F. Petricoin +4 more

Validation of a multicellular tumor microenvironment system for modeling patient tumor biology and drug response

Scientific Reports(2021)10.1038/s41598-021-84612-z
N/A
0DataRank · unranked
6 citations

Stephen A. Hoang, Kristopher D. Rawls, Katherine A. Owen, Michael B. Simmers, Robert A. Figler +5 more

Defining the KRAS-regulated kinome in KRAS-mutant pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.27.441678
N/A
0DataRank · unranked
0 citations

Jennifer E. Klomp, Kayla R. Snare, Devon R. Blake, Priya S. Hibshman, Zane D. Kaiser +13 more

Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100819
N/A
0DataRank · unranked
76 citations

Nicholas W. Bateman, Jianfang Liu, Trinh Mai Nguyen, Teri J. Franks, Xijun Zhang +42 more

Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner

Scientific Reports(2022)10.1038/s41598-022-07394-y
N/A
0DataRank · unranked
9 citations

Molykutty J. Aryankalayil, Michelle A. Bylicky, Adeola Y. Makinde, Lance A. Liotta, Valerie Calvert +4 more